美股市場個股詳情

REKR Rekor Systems

添加自選

1.835
+0.045+2.51%

收盤價 04/29 16:00 (美東)

1.840
+0.005+0.27%

盤前 08:00 (美東)

1.57億總市值-2548市盈率TTM

Rekor Systems股票討論區

登錄發表評論

stockhub

04/15 02:24

Biotech Stocks: Price Action and Logic

I have noticed recently that some shares despite FDA approval, price action is opposite, also earning call sometimes when it beats estimates projection, the market sentiment or price action is in reverse.
Which is more important when picking a trade:
Earning or FDA outcome
Acquisition or Market sentiment
Happy to learn from friends here.
$Enlivex Therapeutics(ENLV.US)$
$Akebia Therapeutics(AKBA.US)$
$Rekor Systems(REKR.US)$
$OncoCyte(OCX.US)$

stockhub

03/29 17:32

This stock gave me a nightmare

$Akebia Therapeutics(AKBA.US)$
I am seeing a similar trend with $Rekor Systems(REKR.US)$
Shorties will keep it down for ever.
Will average down on this. What do you think guys?

Matt the Man

03/26 21:53

$Rekor Systems (REKR.US)$ all good news for rekor but yet the stock price is tanking. such bullshit

73386014

03/13 22:02

$Rekor Systems(REKR.US)$ time to buy!!!

Moomoo AI

03/06 20:02

Rekor Systems' high P/S ratio is likely due to investors' expectations of continued strong revenue performance. The potential for a deterioration in revenues is seen as remote, justifying the elevated P/S ratio.